$6.03 Billion is the total value of Slate Path Capital LP's 12 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 53.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRcall | $4,650,450,000 | – | 21,500,000 | +100.0% | 77.15% | – |
| QQQ | New | POWERSHARES QQQ TRUSTput | $308,672,000 | – | 2,600,000 | +100.0% | 5.12% | – |
| PYPL | PAYPAL HLDGS INC | $240,904,000 | +12.2% | 5,880,000 | 0.0% | 4.00% | -76.2% | |
| CHTR | CHARTER COMMUNICATIONS INC Ncl a | $202,478,000 | +18.1% | 750,000 | 0.0% | 3.36% | -75.0% | |
| GDX | Sell | VANECK VECTORS ETF TRgold miners etf | $155,673,000 | -37.5% | 5,890,000 | -34.5% | 2.58% | -86.7% |
| PODD | INSULET CORP | $111,357,000 | +35.4% | 2,720,000 | 0.0% | 1.85% | -71.3% | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $83,031,000 | +31.8% | 1,225,000 | +7.9% | 1.38% | -72.0% |
| TSO | TESORO CORP | $79,162,000 | +6.2% | 995,000 | 0.0% | 1.31% | -77.5% | |
| AAP | New | ADVANCE AUTO PARTS INC | $68,595,000 | – | 460,000 | +100.0% | 1.14% | – |
| TRIP | Sell | TRIPADVISOR INC | $65,391,000 | -45.8% | 1,035,000 | -44.8% | 1.08% | -88.5% |
| X | Buy | UNITED STATES STL CORP NEW | $51,865,000 | +310.2% | 2,750,000 | +266.7% | 0.86% | -13.0% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $10,160,000 | +7.5% | 475,000 | +13.1% | 0.17% | -77.1% |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -430,000 | -100.0% | -1.72% | – |
| AA | Exit | ALCOA INC | $0 | – | -7,040,000 | -100.0% | -5.10% | – |
| TECK | Exit | TECK RESOURCES LTDcl b | $0 | – | -6,115,000 | -100.0% | -6.30% | – |
| SYMC | Exit | SYMANTEC CORP | $0 | – | -5,505,000 | -100.0% | -8.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
| SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.